Nov. 21, 2024 – The Pennsylvania-based drug maker Endo announced this week that it is expanding its recall of clonazepam tablets because some cartons bear the incorrect drug strength and wrong drug code. The new recall affects 16 lots of Clonazepam Orally Disintegrating Tablets, USP (C-IV), with doses ranging from 0.125 milligrams to 2 milligrams.
The packages feature 10 blister strips that each contain six tablets. They are due to expire between August 2026 and February 2027.
Clonazepam is a benzodiazepine used to treat panic disorder and certain types of seizures.
Endo warns that consuming a higher dose of clonazepam could increase the risk of sleepiness, confusion, dizziness, diminished reflexes and loss of muscle control or strength.
SOBERSTARS! – Jan. 2, 2025 - After successfully completing Dry January, when one gives up alcohol…
DEAD BUT NOT FORGOTTEN – DEC 14, 2024 - Parade annually celebrates the lives of…
VIDEO – SHARING THE MESSAGE – Dec. 24, 2024 - “My husband’s great uncle drank…
SHE’S BAAAACK – Dec. 24, 2024 - Britney is moving into 2025 determined to stay…
VIDEO – SAMPLING NOTHING WORKS – Dec. 25, 2024 - Andrea McCarthy told friends and…
“People can become psychotic.” – Dec. 22, 2024 - Heidi Lawrence’s daughter was 14 when…